Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences
31 août 2022 16h05 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat...
Shockwave Medical Reports Second Quarter 2022 Financial Results
08 août 2022 16h05 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2022 Results and Participation in Upcoming Investor Conference
25 juil. 2022 08h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy
23 mai 2022 07h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely...
Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
19 mai 2022 08h20 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave IVL Coronary Studies Demonstrate Excellent PCI Outcomes in Both Women and Men at One Year
19 mai 2022 07h00 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave Medical Reports First Quarter 2022 Financial Results
09 mai 2022 16h02 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor Conferences
27 avr. 2022 08h00 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
Shockwave Medical Announces Global Launch of New Peripheral Intravascular Lithotripsy Catheter
31 mars 2022 08h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
30 mars 2022 08h30 HE
|
Shockwave Medical, Inc.
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets SANTA CLARA, Calif., March 30, 2022 (GLOBE...